Similar Articles
The Metabolic Syndrome: A Cancer Risk Factor?
Ayça Nur Demir, Kerem Can Tunç, Mehtap Odabaşı, Oytun Erbaş
DOI: 10.5606/jebms.2023.1040
Issue: 2023, Volume 4 - Issue 1
268
306
Emerging Immunotherapeutic Approaches for Managing Metastasis
Alper Demirezen, Oytun Erbaş
DOI: 10.5606/jebms.2023.1050
Issue: 2023, Volume 4 - Issue 2
224
265
Nasopharyngeal Carcinoma: Causes and Incidence
Fatih Özgür Sarıbıyık, Oytun Erbaş
DOI: 10.5606/jebms.2023.1060
Issue: 2023, Volume 4 - Issue 3
90
121
Regulatory T Cells and Their Implications in Cancer Immunotherapy
Saime Sıla Gemici, Oytun Erbaş
DOI: 10.5606/jebms.2023.1064
Issue: 2023, Volume 4 - Issue 3
112
136
Cancer Stem Cells
Alper Demirezen, Oytun Erbaş
DOI: 10.5606/jebms.2024.1083
Issue: 2024, Volume 5 - Issue SPECIAL ISSUE
51
79
Stem Cell Therapy in Cancer
Ayça Nur Demir, Oytun Erbaş
DOI: 10.5606/jebms.2024.1084
Issue: 2024, Volume 5 - Issue SPECIAL ISSUE
51
77